Antipsychotic potential of RO 20 1724, a PDE4 inhibitor

被引：0
|
作者：
Halene, T. B. [1 ]
Siegel, S. J. [1 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
来源：
BEHAVIOURAL PHARMACOLOGY | 2007年 / 18卷
关键词：
D O I：
暂无
中图分类号：
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号：
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要：
引用
收藏
页码：S12 / S12
页数：1
相关论文
共 50 条
  • [41] Safety of the PDE4 inhibitor roflumilast in COPD patients with chronic bronchitis
    Pohl, W.
    Sweilem, M.
    Voves, R.
    Jamnig, H.
    Moll-Schueler, I.
    Martinez, F. J.
    WIENER KLINISCHE WOCHENSCHRIFT, 2010, 122 (21-22) : A58 - A58
  • [42] THE EFFECTS OF THE PDE4 INHIBITOR APREMILAST ON CELLULAR PHYSIOLOGY AND ETHANOL DRINKING
    Mangieri, R. A.
    Aziz, H. C.
    Roberts, A. J.
    Roberto, M.
    Morrisett, R. A.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2018, 42 : 104A - 104A
  • [43] PDE4 Inhibition as Potential Treatment of Epidermolysis Bullosa Acquisita
    Koga, Hiroshi
    Recke, Andreas
    Vidarsson, Gestur
    Pas, Hendri H.
    Jonkman, Marcel F.
    Hashimoto, Takashi
    Kasprick, Anika
    Ghorbanalipoor, Saeedeh
    Tenor, Hermann
    Zillikens, Detlef
    Ludwig, Ralf J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (11) : 2211 - 2220
  • [44] A PDE4 shortform degrader: a first in isoform-specific PDE4 inhibition
    Maurice, Donald H.
    FEBS JOURNAL, 2025,
  • [45] Potential of the rat model of conditioned gaping to detect nausea produced by rolipram, a phosphodiesterase-4 (PDE4) inhibitor
    Rock, Erin M.
    Benzaquen, Jessica
    Limebeer, Cheryl L.
    Parker, Linda A.
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2009, 91 (04) : 537 - 541
  • [46] COPD: PDE4 inhibitor Roflumilast - from the symptom to the disease interference
    不详
    MEDIZINISCHE KLINIK, 2006, 101 (12) : XI - XII
  • [47] Reduction in systemic inflammation by the PDE4 inhibitor roflumilast in patients with COPD
    -Martin, Eduardo Marquez
    Ruiz, Francisco Ortega
    Campano, Elena
    De la Horra, Carmen
    Varela, Jose Manuel
    Calderon, Enrique
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [48] Synthesis and profile of SCH351591, a novel PDE4 inhibitor
    Billah, M
    Cooper, N
    Cuss, F
    Davenport, RJ
    Dyke, HJ
    Egan, R
    Ganguly, A
    Gowers, L
    Hannah, DR
    Haughan, AF
    Kendall, HJ
    Lowe, C
    Minnicozzi, M
    Montana, JG
    Naylor, R
    Oxford, J
    Peake, JC
    Piwinski, JJ
    Runcie, KA
    Sabin, V
    Sharpe, A
    Shih, NY
    Warneck, JBH
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (12) : 1621 - 1623
  • [49] First PDE4 inhibitor for psoriasis hits the market but impact is uncertain
    Ratner, Mark
    NATURE BIOTECHNOLOGY, 2014, 32 (06) : 505 - 507
  • [50] An application of GASP to reduce the emesis potential in the PDE4 inhibitors
    Andrianjara, CR
    Wrigglesworth, R
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 1998, 16 (4-6): : 287 - 287
12345